Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock

Analysts' ratings for Tempus AI TEM over the last quarter vary from bullish to bearish, as provided by 6 analysts.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Analysts have recently evaluated Tempus AI and provided 12-month price targets. The average target is $63.17, accompanied by a high estimate of $74.00 and a low estimate of $54.00. Observing a 30.92% increase, the current average has risen from the previous average price target of $48.25.

Diving into Analyst Ratings: An In-Depth Exploration

A comprehensive examination of how financial experts perceive Tempus AI is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Tempus AI. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tempus AI compared to the broader market.
• Price Targets: Delving into movements, analysts provide estimates for the future value of Tempus AI's stock. This analysis reveals shifts in analysts' expectations over time.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Tempus AI's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Tempus AI analyst ratings.

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Tempus AI's Economic Impact: An Analysis

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Revenue Growth: Tempus AI displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 32.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -41.92%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Tempus AI's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -99.8%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Tempus AI's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -8.26%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Tempus AI's debt-to-equity ratio stands notably higher than the industry average, reaching 8.78. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

Analyst Ratings: What Are They?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.